L. Baddour, W. Wilson, and A. Bayer, Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications, Circulation, vol.132, issue.15, pp.1435-86, 2015.
DOI : 10.1161/CIR.0000000000000296

G. Habib, P. Lancellotti, and M. Antunes, 2015 ESC Guidelines for the management of infective endocarditis, European Heart Journal, vol.36, issue.44, 2015.
DOI : 10.1093/eurheartj/ehv319
URL : https://hal.archives-ouvertes.fr/hal-01466878

E. Ribera, J. Gomez-jimenez, and E. Cortes, Endocarditis, Annals of Internal Medicine, vol.125, issue.12, pp.969-74, 1996.
DOI : 10.7326/0003-4819-125-12-199612150-00005

S. Cosgrove, G. Vigliani, V. Fowler, and . Jr, Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.48, issue.6, pp.713-734, 2009.

C. Watanakunakorn and I. Baird, Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin, The American Journal of the Medical Sciences, vol.273, issue.2, pp.133-142, 1977.
DOI : 10.1097/00000441-197703000-00002

M. Sande and M. Johnson, Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus, Journal of Infectious Diseases, vol.131, issue.4, pp.367-75, 1975.
DOI : 10.1093/infdis/131.4.367

P. Grohs, M. Kitzis, and L. Gutmann, In Vitro Bactericidal Activities of Linezolid in Combination with Vancomycin, Gentamicin, Ciprofloxacin, Fusidic Acid, and Rifampin against Staphylococcus aureus, Antimicrobial Agents and Chemotherapy, vol.47, issue.1, pp.418-438, 2003.
DOI : 10.1128/AAC.47.1.418-420.2003

G. Beraud, L. Moal, G. Elsendoorn, and A. , A survey on the use of gentamicin in infective endocarditis. European journal of clinical microbiology & infectious diseases : official publication of the European Society of, Clinical Microbiology, vol.31, issue.7, pp.1413-1421, 2012.

M. Carugati, A. Bayer, and J. Miro, High-Dose Daptomycin Therapy for Left-Sided Infective Endocarditis: a Prospective Study from the International Collaboration on Endocarditis, Antimicrobial Agents and Chemotherapy, vol.57, issue.12, pp.6213-6235, 2013.
DOI : 10.1128/AAC.01563-13

R. Kullar, A. Casapao, and S. Davis, A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis, Journal of Antimicrobial Chemotherapy, vol.68, issue.12, pp.2921-2927, 2013.
DOI : 10.1093/jac/dkt294

J. Mainardi, L. Gutmann, J. Acar, and F. Goldstein, Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis [published erratum appears in Antimicrob Agents Chemother 1995 Dec;39(12):2835], Antimicrobial Agents and Chemotherapy, vol.39, issue.9, pp.1984-1991, 1995.
DOI : 10.1128/AAC.39.9.1984

J. Casalta, C. Zaratzian, and S. Hubert, Treatment of Staphylococcus aureus endocarditis with high doses of trimethoprim/sulfamethoxazole and clindamycin???Preliminary report, International Journal of Antimicrobial Agents, vol.42, issue.2, pp.190-191, 2013.
DOI : 10.1016/j.ijantimicag.2013.05.002

N. Markowitz, E. Quinn, and L. Saravolatz, Trimethoprim-Sulfamethoxazole Compared with Vancomycin for the Treatment of Staphylococcus aureus Infection, Annals of Internal Medicine, vol.117, issue.5, pp.390-398, 1992.
DOI : 10.7326/0003-4819-117-5-390

M. Paul, J. Bishara, and D. Yahav, Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial, BMJ, vol.350, issue.may14 24, p.2219, 2015.
DOI : 10.1136/bmj.h2219
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431679

C. Watanakunakorn, Clindamycin therapy of staphylococcus aureus endocarditis, The American Journal of Medicine, vol.60, issue.3, pp.419-444, 1976.
DOI : 10.1016/0002-9343(76)90758-0

G. Habib, B. Hoen, and P. Tornos, Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer, European heart journal, vol.30, pp.2369-413, 2009.

M. Paul, N. Zemer-wassercug, and O. Talker, Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.17, issue.10, pp.1581-1587, 2011.

N. Fernandez-hidalgo, B. Almirante, and J. Gavalda, Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating enterococcus faecalis infective endocarditis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.56, issue.9, pp.1261-1269, 2013.

J. Pericas, C. Cervera, and A. Del-rio, Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone. Clinical microbiology and infection : the official publication of the European Society of, Clinical Microbiology and Infectious Diseases, vol.20, issue.12, pp.1075-83, 2014.